3-[(3,5-Dimethylphenyl)ethylamino]-2-hydroxy-1-propanesulfonic Acid Sodium Salt(CAS: 82692-97-5)

This compound falls under the scope of various regulatory guidelines such as GHS for hazardous classification, REACH for registration, evaluation, and authorization in the European Union, and FDA for safety and usage in pharmaceuticals. EPA regulations also apply for environmental safety concerns. Compliance with these guidelines is essential for handling, storage, and disposal of the compound.

Alternatives include similar functional group compounds like 3-[(4-methylphenyl)ethylamino]-2-hydroxy-1-propanesulfonic acid sodium salt or its isomers. Common substitutes in synthesis include related amino acid derivatives or organic amines. When selecting alternatives, consider the specific chemical properties and desired reaction outcomes.

Market trends indicate growing interest in this compound due to its potential applications in pharmaceuticals and cosmetics. Research is focusing on its biological activities and potential as a drug candidate. The compound's unique chemical structure makes it a focus in emerging fields such as anti-inflammatory and anti-cancer therapies. Demand is expected to increase with further validation of its properties.

Waste containing this compound should be collected in appropriate containers and stored in a secure, well-ventilated area. For disposal, incineration or professional waste disposal services are recommended. Ensure compliance with local regulations and guidelines to prevent environmental contamination. Always wear protective equipment and follow safety protocols during handling and disposal to minimize risk to health and the environment.